  | |
| Education | : | Ph.D in Medicinal Chemistry, University of Michigan,USA | | Experience | : | Professor and Director, Medical Laboratories, National Defense Medical Center (1986-1996).
Chairman, School of Pharmacy (2000-2005).
Dean, Office of Research and Development, National Taiwan University (2006~ 2012).
Chairman, Center for innovative Therapeutics Discovery, NTU (2013~now). | | Honor | : | Fellow, American Association for the Advancement of Science, 2001. | | Research Areas | : | Design and developement of new drugs, Heterocyclic Chemistry, Pharmaceutical Chemistry | | Lab Focus | : | This laboratory is focused on the new anticancer, antiviral, CNS and cardio- vascular drug discovery. The approaches are taken by either generating the hypothetic 3D structure through existing compounds through computer modeling program or directly using the X-Ray 3D structure of enzymatic protein, followed a virtually high through-put screening via docking through a variety of data bases to provide a new ead compound. Then the traditional approaches toward the lead optimization for new drug development are applied . On the basis of these approaches , current ongoing research projects include : design and synthesis of selective A1a-adrenoceptor and 5a-reductase inhibitor for the treatment of benign hypertrophy , design and synthesis of helicase inhibitors against hepatitis C, design and synthesis of adenosine A1 agonist for the treatment of arrhythmia,design and synthesis multi-drug resistance tumor reversing agents, and design and synthesis of tyrosine kinase inhibitors. |
|
